318 related articles for article (PubMed ID: 1869824)
1. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
2. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
Weyand CM; Hicok KC; Goronzy JJ
J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
4. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
[TBL] [Abstract][Full Text] [Related]
5. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
6. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
Signorelli KL; Watts LM; Lambert LE
Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
[TBL] [Abstract][Full Text] [Related]
7. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of binding capacities between HLA class II molecules and synthetic peptides HA307-319].
Ikeda K; Katagiri M
Hokkaido Igaku Zasshi; 1993 May; 68(3):318-24. PubMed ID: 8319931
[TBL] [Abstract][Full Text] [Related]
9. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
11. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
Lee JM; McKean DJ; Watts TH
J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
[TBL] [Abstract][Full Text] [Related]
12. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
[TBL] [Abstract][Full Text] [Related]
13. MHC class II binding of peptides derived from HLA-DR 1.
Harris PE; Liu Z; Suciu-Foca N
J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
[TBL] [Abstract][Full Text] [Related]
14. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility.
Gao X; Gazit E; Livneh A; Stastny P
J Rheumatol; 1991 Jun; 18(6):801-3. PubMed ID: 1895259
[TBL] [Abstract][Full Text] [Related]
16. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
Hill CM; Hayball JD; Allison AA; Rothbard JB
J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele "DR-BON".
Coppin HL; Avoustin P; Fabron J; Huchenq A; Garnier JM; Thomsen M; De Preval C
J Immunol; 1990 Feb; 144(3):984-9. PubMed ID: 1688595
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.
Ostrov D; Krieger J; Sidney J; Sette A; Concannon P
J Immunol; 1993 May; 150(10):4277-83. PubMed ID: 8482836
[TBL] [Abstract][Full Text] [Related]
19. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.
Roche PA; Cresswell P
J Immunol; 1990 Mar; 144(5):1849-56. PubMed ID: 2307844
[TBL] [Abstract][Full Text] [Related]
20. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
Long EO; LaVaute T; Pinet V; Jaraquemada D
J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
